Aversano Francis J, Goldfarb Charles A, Gelberman Richard H, Calfee Ryan P
Department of Orthopedic Surgery, Washington University in St. Louis, School of Medicine, St. Louis, MO.
Department of Orthopedic Surgery, Washington University in St. Louis, School of Medicine, St. Louis, MO.
J Hand Surg Am. 2022 Oct;47(10):944-952. doi: 10.1016/j.jhsa.2022.06.017. Epub 2022 Aug 6.
Considering the cost of, discomfort with, and time required for nerve conduction testing, the Carpal Tunnel Syndrome-6 (CTS-6) is often used to determine the likelihood of the presence of carpal tunnel syndrome. We sought to determine whether the CTS-6, designed as a diagnostic instrument, could serve a dual purpose and predict the outcome of carpal tunnel release (CTR) based on postoperative changes in the Boston Carpal Tunnel Questionnaire (BCTQ) score.
This prospective observational study enrolled 118 adults before they underwent open CTR at a tertiary center. A primary regression analysis was used to determine the association between preoperative CTS-6 scores and changes in the BCTQ score at ≥6 months after surgery. Additional demographic, social, electrodiagnostic, and mental health variables were assessed for associations with changes in the BCTQ score. The secondary outcomes included single questions rating satisfaction with the result of CTR as well as symptom changes and the Decision Regret Scale. Noneffective CTR was defined as a BCTQ score change of <1.0 point or reported dissatisfaction.
Postoperatively, the BCTQ score improvement averaged 1.38 ± 0.77. Although 102 of 109 patients (94%) noted symptom improvement, 94 of 109 (86%) were satisfied with the result of CTR, and 78 of 109 patients (72%) demonstrated a meaningful change in the BCTQ score. Preoperative CTS-6 scores were not correlated with changes in BCTQ scores. CTS-6 scores were not associated with Decision Regret Scale scores, reported satisfaction, or the single-question assessment of symptom changes. Satisfaction, decision regret, and the single symptom change question were correlated with changes in the BCTQ score and each other. Dissatisfied patients were distinguished by a differential improvement in the BCTQ score (1.5 vs 0.7), but no preoperative variable consistently predicted noneffective CTR.
The CTS-6 score does not predict changes in BCTQ scores after CTR. Patient satisfaction with surgical results is associated with postoperative changes in carpal tunnel symptoms but is not predictable using preoperative information. A single question of symptom change may offer an efficient assessment of CTR outcomes.
TYPE OF STUDY/LEVEL OF EVIDENCE: Prognostic II.
考虑到神经传导测试的成本、不适感以及所需时间,腕管综合征6项指标(CTS - 6)常被用于判定腕管综合征存在的可能性。我们试图确定,作为一种诊断工具设计的CTS - 6是否能起到双重作用,并根据波士顿腕管问卷(BCTQ)评分的术后变化来预测腕管松解术(CTR)的结果。
这项前瞻性观察性研究纳入了118名在三级中心接受开放性CTR手术前的成年人。采用一次回归分析来确定术前CTS - 6评分与术后≥6个月时BCTQ评分变化之间的关联。评估了其他人口统计学、社会、电诊断和心理健康变量与BCTQ评分变化的关联。次要结局包括对CTR结果满意度的单项问题评分以及症状变化和决策后悔量表。无效CTR被定义为BCTQ评分变化<1.0分或报告不满意。
术后,BCTQ评分平均改善1.38±0.77。虽然109例患者中有102例(94%)症状改善,但109例中有94例(86%)对CTR结果满意,109例患者中有78例(72%)BCTQ评分有显著变化。术前CTS - 6评分与BCTQ评分变化无相关性。CTS - 6评分与决策后悔量表评分、报告的满意度或症状变化的单项问题评估均无关联。满意度、决策后悔和单项症状变化问题与BCTQ评分变化相互关联。不满意的患者在BCTQ评分改善方面存在差异(1.5对0.7),但没有术前变量能始终预测无效CTR。
CTS - 6评分不能预测CTR术后BCTQ评分的变化。患者对手术结果的满意度与腕管症状的术后变化相关,但无法用术前信息预测。一个关于症状变化的单项问题可能会提供对CTR结果的有效评估。
研究类型/证据水平:预后性II级。